Hybrid iFR-FFR decision-making strategy: implications for enhancing universal adoption of physiology-guided coronary revascularisation
EuroIntervention 2013;8:1157-1165 published online ahead of print December 2012. DOI: 10.4244/EIJV8I10A179
Ricardo Petraco1*, MD; Jin Joo Park3, MD; Sayan Sen1, MBBS; Sukhjinder S. Nijjer1, MBChB; Iqbal S. Malik1, MBBS, PhD; Mauro Echavarría-Pinto², MD; Kaleab N. Asrress6, MA, BM, BCh; Chang-Wook Nam4, MD, PhD; Enrico Macías², MD; Rodney A. Foale1, MD; Amarjit Sethi1, MBBS, PhD; Ghada W. Mikhail1, MBBS, MD; Raffi Kaprielian1, MBBS, MD; Christopher S. Baker1, MBBS, PhD; David Lefroy1, MB, BChir; Michael Bellamy1, MBBS, MD; Mahmud Al-Bustami1, MD; Masood A. Khan1, MB, BChir, MA; Nieves Gonzalo², MD, PhD; Alun D. Hughes
1. International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom; 2. Cardiovascular Institute, Hospital Clínico San Carlos, Madr
Aims: Adoption of fractional flow reserve (FFR) remains low (6-8%), partly because of the time, cost and potential inconvenience associated with